مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

2,921
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

SURVEY OF THE STATUS OF ESTROGEN AND PROLACTIN RECEPTORS IN BREAST CANCER

Pages

  137-142

Abstract

 Background and Objective: The existence of hormonal receptors in cancer cells is very important in various aspects. Survey of the status of ESTROGEN RECEPTORs (ERs) in the evaluation of BREAST CANCER cells is important due to their response to hormonal therapy. Many studies have been recently carried out on PROLACTIN RECEPTORs (PRLRs) especially in BREAST CANCER. The aim of the present study was survey of the status of ERs and PRLRs in BREAST CANCER.Materials and Methods: In this cross-sectional study 40 samples from BREAST CANCER tumors were studied. ESTROGEN RECEPTOR was assessed by radio-ligand binding assay method. Free and total PROLACTIN RECEPTORs were also measured using iodinated prolactin (125I-PRL). Magnesium chloride solution (3.5 M) was used to assay the total PROLACTIN RECEPTOR.Results: Eighty five percent of tumor samples were ductal tubular carcinoma. In 62.5%, 45% and 62.5% of tumor samples ER, free PRLR and total PRLR were observed respectively. Forty Five percent of the tumor cells expressed both ER and total PRLR. A positive significant relation between ER and free PRLR was observed (p<0.05). There was also a significant relation (p<0.05) between ER and total PRLR. Twenty Percent of tumor cells expressed neither ER nor total PRLR.Conclusion: Since the existence of estrogen and PROLACTIN RECEPTORs in breast tumor cells have been shown, application of antiestrogenic and antiprolactin drugs in the inhibition of these tumors growth are possibly of value.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    SIRATI SABET, M., & KARAMI TEHRANI, FATEMEH. (2006). SURVEY OF THE STATUS OF ESTROGEN AND PROLACTIN RECEPTORS IN BREAST CANCER. JOURNAL OF RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES, 5(3), 137-142. SID. https://sid.ir/paper/71200/en

    Vancouver: Copy

    SIRATI SABET M., KARAMI TEHRANI FATEMEH. SURVEY OF THE STATUS OF ESTROGEN AND PROLACTIN RECEPTORS IN BREAST CANCER. JOURNAL OF RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES[Internet]. 2006;5(3):137-142. Available from: https://sid.ir/paper/71200/en

    IEEE: Copy

    M. SIRATI SABET, and FATEMEH KARAMI TEHRANI, “SURVEY OF THE STATUS OF ESTROGEN AND PROLACTIN RECEPTORS IN BREAST CANCER,” JOURNAL OF RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES, vol. 5, no. 3, pp. 137–142, 2006, [Online]. Available: https://sid.ir/paper/71200/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top